Get started
Author

Ryan C. Lynch

Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1
2009 · Kwan-Hyuck Baek, Alexander Zaslavsky, et al. · Nature · 374
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
2019 · Alexandre V. Hirayama, Jordan Gauthier, et al. · Blood · 354
PDF
TORC1 Is Essential for NF1-Associated Malignancies
2008 · Cory M. Johannessen, Bryan W. Johnson, et al. · Current Biology · 203
PDF
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
2021 · Michael A. Thompson, Jeffrey P. Henderson, et al. · JAMA Oncology · 192
PDF
Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis
2010 · Alexander Zaslavsky, Kwan-Hyuck Baek, et al. · Blood · 191
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
2020 · Richard T. Hoppe, Ranjana H. Advani, et al. · Journal of the National Comprehensive Cancer Network · 154
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch
2006 · Sylvie Giuriato, Sandra Ryeom, et al. · Proceedings of the National Academy of Sciences · 149
Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy
2019 · Victor A. Chow, Ajay K. Gopal, et al. · American Journal of Hematology · 135
Targeted Deletion of the Calcineurin Inhibitor DSCR1 Suppresses Tumor Growth
2008 · Sandra Ryeom, Kwan-Hyuck Baek, et al. · Cancer Cell · 134
PDF
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
2023 · Stefan K. Alig, Mohammad Shahrokh Esfahani, et al. · Nature · 111
PDF
Pembrolizumab with R‐CHOP in previously untreated diffuse large B‐cell lymphoma: potential for biomarker driven therapy
2020 · Stephen D. Smith, Brian G. Till, et al. · British Journal of Haematology · 96
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
2021 · Reid W. Merryman, Luca Castagna, et al. · Leukemia · 82
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022
2022 · Richard T. Hoppe, Ranjana H. Advani, et al. · Journal of the National Comprehensive Cancer Network · 79
PDF
Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer
2022 · Julie Fu, Sonya A. Reid, et al. · JAMA Network Open · 66
PDF
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study
2021 · Ryan C Lynch, Ryan D Cassaday, et al. · The Lancet Haematology · 61
Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma
2015 · Kenneth R. Carson, Peter Riedell, et al. · Journal of Geriatric Oncology · 61
Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs
2004 · Yulei Shen, Javeed Iqbal, et al. · BMC Immunology · 61
PDF
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
2022 · Ziad Bakouny, Chris Labaki, et al. · JAMA Oncology · 54
PDF
Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B‐cell lymphoma treated with CHOP‐based chemotherapy
2016 · Daphne Y. Xiao, Suhong Luo, et al. · American Journal of Hematology · 54
PDF
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma
2021 · Reid W. Merryman, Robert A. Redd, et al. · Blood Advances · 50
Practical Limitations of Bioresorbable Membranes in the Prevention of Intra-Abdominal Adhesions
2008 · Rizal Lim, Jonathan M. Morrill, et al. · Journal of Gastrointestinal Surgery · 48
Clinical Impact of the 2016 Update to the WHO Lymphoma Classification
2017 · Ryan C. Lynch, Dita Gratzinger, et al. · Current Treatment Options in Oncology · 42
Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma
2023 · Ryan C Lynch, Chaitra S Ujjani, et al. · Blood · 38
PDF
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
2021 · Andrew L. Schmidt, Matthew D. Tucker, et al. · JAMA Network Open · 38
PDF
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma
2025 · Mark Roschewski, David M. Kurtz, et al. · Journal of Clinical Oncology · 36
Works count: 229
Citation count: 3,766
H-index: 28
I10-index: 65
Year
Topic
Type